What is China Dasheng Biotechnology Company's annual revenue?

China Dasheng Biotechnology Company (CDBT) reported annual revenue of $0 in its most recent fiscal year.

What is China Dasheng Biotechnology Company's net profit?

China Dasheng Biotechnology Company (CDBT) reported net profit of $-1.0M in its most recent fiscal year.

What is CDBT EV/EBITDA?

China Dasheng Biotechnology Company's enterprise value to EBITDA (EV/EBITDA) ratio is -8.04.

OTC · Financial Statements

China Dasheng Biotechnology Company (CDBT) Financial Statements

$0.10 OTC: CDBT Market Cap $4.10M

China Dasheng Biotechnology Company most recently reported annual revenue of $0, net profit of $-1.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric	2005	2006	2007	2021	2022
Revenue	$0	$0	$16.0M	—	$0
Operating Profit	$0	$0	$5.0M	—	$-1.0M
Net Profit	$0	$0	$5.0M	—	$-1.0M
EPS	$0.00	$-0.01	$0.15	—	$-0.02
Op Margin	-3.5%	—	31.1%	—	—

Balance Sheet (USD)

Metric	2005	2006	2007	2021	2022
Total Assets	$0	—	$20.0M	$0	$0
Total Liabilities	$0	—	$3.0M	$0	$2.0M
Cash	$0	—	$2.0M	$0	$0
Borrowings	$0	$0	$0	$0	$1.0M

Cash Flow (USD)

Metric	2005	2006	2007	2021	2022
Operating Cash Flow	$0	—	$4.0M	—	$0
Investing Cash Flow	$0	—	$-4.0M	—	$0
Financing Cash Flow	$0	—	$0	—	$0
Net Cash Flow	$0	—	$0	—	$0
Free Cash Flow	$0	$0	$4.0M	$0	$0

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.06
EV / EBITDA	-8.04
FCF Yield	-5.70%
Quick Ratio	0.07
Interest Coverage	-1.83
Return 1Y	—
Return 3Y	—
Return 5Y	—

Screens featuring this stock

High ROE Financial Services Stocks Low P/E Financial Services Stocks High Net Margin Financial Services Stocks Dividend Financial Services Stocks Low Debt Financial Services Stocks All stock screens

CDBT Overview CDBT Dividend Run Stock Screener